X-9743555-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000273.3(GPR143):c.767+10C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.216 in 1,012,845 control chromosomes in the GnomAD database, including 17,349 homozygotes. There are 67,243 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.17 ( 1385 hom., 5467 hem., cov: 22)
Exomes 𝑓: 0.22 ( 15964 hom. 61776 hem. )
Consequence
GPR143
NM_000273.3 intron
NM_000273.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.347
Genes affected
GPR143 (HGNC:20145): (G protein-coupled receptor 143) This gene encodes a protein that binds to heterotrimeric G proteins and is targeted to melanosomes in pigment cells. This protein is thought to be involved in intracellular signal transduction mechanisms. Mutations in this gene cause ocular albinism type 1, also referred to as Nettleship-Falls type ocular albinism, a severe visual disorder. A related pseudogene has been identified on chromosome Y. [provided by RefSeq, Dec 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant X-9743555-G-C is Benign according to our data. Variant chrX-9743555-G-C is described in ClinVar as [Benign]. Clinvar id is 255712.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-9743555-G-C is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.303 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GPR143 | NM_000273.3 | c.767+10C>G | intron_variant | ENST00000467482.6 | NP_000264.2 | |||
GPR143 | XM_005274541.4 | c.767+10C>G | intron_variant | XP_005274598.1 | ||||
GPR143 | XM_024452388.2 | c.515+10C>G | intron_variant | XP_024308156.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GPR143 | ENST00000467482.6 | c.767+10C>G | intron_variant | 1 | NM_000273.3 | ENSP00000417161 | P1 | |||
GPR143 | ENST00000447366.5 | c.515+10C>G | intron_variant | 3 | ENSP00000390546 | |||||
GPR143 | ENST00000431126.1 | downstream_gene_variant | 3 | ENSP00000406138 |
Frequencies
GnomAD3 genomes AF: 0.170 AC: 18893AN: 110810Hom.: 1384 Cov.: 22 AF XY: 0.165 AC XY: 5460AN XY: 33072
GnomAD3 genomes
AF:
AC:
18893
AN:
110810
Hom.:
Cov.:
22
AF XY:
AC XY:
5460
AN XY:
33072
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.203 AC: 37159AN: 182915Hom.: 2562 AF XY: 0.221 AC XY: 14883AN XY: 67399
GnomAD3 exomes
AF:
AC:
37159
AN:
182915
Hom.:
AF XY:
AC XY:
14883
AN XY:
67399
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.222 AC: 200283AN: 901983Hom.: 15964 Cov.: 17 AF XY: 0.235 AC XY: 61776AN XY: 263049
GnomAD4 exome
AF:
AC:
200283
AN:
901983
Hom.:
Cov.:
17
AF XY:
AC XY:
61776
AN XY:
263049
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.170 AC: 18892AN: 110862Hom.: 1385 Cov.: 22 AF XY: 0.165 AC XY: 5467AN XY: 33134
GnomAD4 genome
AF:
AC:
18892
AN:
110862
Hom.:
Cov.:
22
AF XY:
AC XY:
5467
AN XY:
33134
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Ocular albinism, type I Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Aug 10, 2021 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Nystagmus 6, congenital, X-linked Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Aug 10, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at